Interventional Cardiology

This cardiac subspecialty uses minimally invasive, catheter-based technologies in a cath lab to diagnose and treat coronary artery disease (CAD). The main focus in on percutaneous coronary interventions (PCI) to revascularize patients with CAD that is causing blockages resulting in ischemia or myocardial infarction. PCI mainly consists of angioplasty and implanting stents. Interventional cardiology has greatly expanded in scope over recent years to include a number of transcatheter structural heart interventions.

First Pennsylvania Patient Treated in Landmark Heart Artery Stent Trial

PinnacleHealth CardioVascular Institute enrolled the first patient in Pennsylvania in a trial assessing the safety and effectiveness of a new stent to treat patients with coronary heart disease who are at higher risk for bleeding.

Recent respiratory infections multiply risk of heart attack

Australian researchers have announced patients who recently had respiratory infections are 17 times more likely to experience heart attack. The findings, published in the Internal Medicine Journal, could be related to such infections activating blood cells and the body's clotting system.

SCAI 2017: Robotic PCI highly successful with transradial, transfemoral access

The May 12 late-breaking clinical trial at the Society for Cardiovascular Angiography and Interventions (SCAI) 2017 Scientific Sessions in New Orleans compared femoral and radial robotic percutaneous coronary intervention (PCI) procedures.

New Data from PLATINUM Diversity Study Presented at SCAI 2017 Provide Important Insights Beyond Traditional Clinically-Reported Endpoints

NEW ORLEANS and MARLBOROUGH, Mass., May 12, 2017 /PRNewswire/ -- New analyses from the Boston Scientific Corporation (NYSE: BSX) sponsored PLATINUM Diversity study underscore the need for greater understanding of the clinical and nonclinical barriers that can adversely affect stent-related outcomes. Aligned with the Boston Scientific "Close the Gap" health equity initiative, PLATINUM Diversity is a first-of-its-kind study focusing exclusively on women and minorities with coronary artery disease that is designed to shed light into the clinical, social, behavioral and economic determinants of health treatment outcome disparities in these groups.

NSAIDs boost heart attack risk within a week of use

Painkillers can increase users’ risk for heart attack within a week of usage, according to a new study published in the BMJ.

Thumbnail

Researchers reduce donor heart rejection with desensitizing antibodies

On the 50th anniversary of using heart transplantation to save lives, researchers from the Pitié-Salpêtrière Hospital in Paris revealed a technique that could reduce the risk of patients rejecting donor hearts.

Patients with degenerative mitral valve disease see better results with experienced surgeons

A database analysis in New York found that the mitral valve case volume of individual surgeons had a significant impact on patient outcomes following surgery.

Thumbnail

Communication, coordination among hospital leaders and physicians improve surgical outcomes

In October 2010, some hospitals in South Carolina began implementing a customized surgical safety checklist patterned after a checklist that the World Health Organization developed. Hospitals implemented the 12-step process that focused on teamwork, training and monitoring progress.

Around the web

Several key trends were evident at the Radiological Society of North America 2024 meeting, including new CT and MR technology and evolving adoption of artificial intelligence.

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.